SHARES PLUMMETS AFTER NOVO NORDISK DEAL BREAKDOWN

Shares of HIMS experienced a dramatic slump today following the unexpected termination of its agreement with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending HIMS's stock price plummeting by nearly 20%. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate that it